Production (Stage)
Korro Bio, Inc.
KRRO
$14.44
-$0.15-1.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.75% | -2.97% | -22.33% | -24.23% | -26.64% |
| Total Depreciation and Amortization | 14.58% | -1.79% | -2.92% | 5.98% | 26.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.04% | 6.28% | 89.84% | 155.85% | 185.03% |
| Change in Net Operating Assets | 1,851.38% | 217.32% | 1.64% | 453.86% | 140.87% |
| Cash from Operations | 9.86% | 10.71% | -20.38% | -8.89% | -14.77% |
| Capital Expenditure | -3.99% | -128.46% | -138.47% | -49.47% | -116.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3,727.25% | -654.97% | -543.11% | -404.07% | -95.59% |
| Cash from Investing | -755.19% | -1,204.86% | -868.40% | -586.81% | -124.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -55.13% | -55.13% | 61,229.48% | 142,280.77% | 160,983.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -265.03% | -5,219.91% | -7,966.00% |
| Cash from Financing | -51.31% | -63.06% | 393.23% | 362.88% | 213.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -223.98% | -186.65% | 908.33% | 683.82% | 154.63% |